• A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study.

      Imamura, Fumiaki; Sharp, Stephen J; Koulman, Albert; Schulze, Matthias B; Kröger, Janine; Griffin, Julian L; Huerta, José M; Guevara, Marcela; Sluijs, Ivonne; Agudo, Antonio; Ardanaz, Eva; Balkau, Beverley; Boeing, Heiner; Chajes, Veronique; Dahm, Christina C; Dow, Courtney; Fagherazzi, Guy; Feskens, Edith J M; Franks, Paul W; Gavrila, Diana; Gunter, Marc; Kaaks, Rudolf; Key, Timothy J; Khaw, Kay-Tee; Kühn, Tilman; Melander, Olle; Molina-Portillo, Elena; Nilsson, Peter M; Olsen, Anja; Overvad, Kim; Palli, Domenico; Panico, Salvatore; Rolandsson, Olov; Sieri, Sabina; Sacerdote, Carlotta; Slimani, Nadia; Spijkerman, Annemieke M W; Tjønneland, Anne; Tumino, Rosario; van der Schouw, Yvonne T; Langenberg, Claudia; Riboli, Elio; Forouhi, Nita G; Wareham, Nick J (2017-10)
      Combinations of multiple fatty acids may influence cardiometabolic risk more than single fatty acids. The association of a combination of fatty acids with incident type 2 diabetes (T2D) has not been evaluated.